Exits
Agios Pharmaceuticals concludes initial public offering of 6.7 mln shares
Cancer metabolism specialist Agios Pharmaceuticals closes its initial public offering on Monday. Agios Pharmaceuticals Inc. announced the conclusion of its initial public offering (IPO) of 6,772,221 shares of the company's common stock at a final offering price of US$18 per share.
Abraaj Group sells stake in insurer’s service firm to Malaysian state-investment fund
Abraaj Group sells its 50% stake in health insurance provider Acıbadem Sağlık ve Hayat Sigorta. The Abraaj Group on Monday announced that it is selling its stake in Acıbadem Sağlık ve Hayat Sigorta A.
LDC Finance to pay back US$4.9 million to secured investors
Secured investors of failed New Zealand-based company LDC Finance will be getting their money back plus interest following the settlement reached with Finance & Investments Partnership.
OzForex hires Goldman Sachs, Macquarie for AUD$500 million IPO
Carlyle Group-backed OzForex is set to pursue AUD$500 million initial public offering for 2013. Global payments provider OzForex acquired the services of Goldman Sachs Group Inc.